Parnell Pharmaceuticals Holdings Ltd Announces $20 Million Secured Term Loan Facility
November 22, 2016 22:33 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Nov. 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Nine-Month Period Ended September 30, 2016
November 02, 2016 16:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell to Report Financial Results for the Nine Months Ended September 30, 2016 on November 2, 2016
October 27, 2016 15:49 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Six-Month Period Ended June 30, 2016
August 04, 2016 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Aug. 04, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell to Report Financial Results for the Six Months Ended June 30, 2016 on August 4, 2016
July 26, 2016 17:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., July 26, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Contract Manufacturing Agreement with Merial
May 31, 2016 16:05 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., May 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell Pharmaceuticals Holdings Ltd Announces Pricing of an Underwritten Public Offering of Common Stock
May 12, 2016 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., May 12, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell Pharmaceuticals Holdings Ltd Announces First Quarter Business Update
April 22, 2016 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
Parnell continues to grow rapidly with revenue increasing 43% for the three months ended March 31, 2016OVERLAND PARK, Kan., April 22, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd...
Parnell to Report Business Results for the Three Months Ended March 31, 2016 on April 22, 2016
April 18, 2016 16:05 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., April 18, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies Animal Health Summit
March 31, 2016 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., March 31, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...